Pulmonary Arterial Hypertension: Research
The question
To ask the Secretary of State for Science, Innovation and Technology, how much funding the Government provided for research into idiopathic pulmonary hypertension in the 2023-24 financial year; and which public bodies provided that funding.
Answered by Feryal Clark
The Department of Health and Social Care funds medical research through the National Institute for Health and Care Research (NIHR). NIHR did not commit any specific funding for idiopathic pulmonary hypertension research in the 2023-24 financial year.
UKRI’s Medical Research Council (MRC) plays a key role in funding both disease specific and underpinning research which may not be attributable to a specific condition but will benefit medical research more generally. UKRI delivers a substantial portfolio of researcher-led projects which includes work on blood vessel function/dysfunction and on fibrosis which is relevant to this condition. The total commitment across UKRI in 2023-24 for idiopathic pulmonary hypertension research was £1,360,310 for 1 award (MRC funded).
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →